TickerFacts.

NP Life Sciences Health Industry Group Inc. (ACAT): Revenue

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$164.6K
Year ended 2023-12-31
+122.2%
3-year compound annual growth
2019-12-31: $43.0K2020-12-31: $15.0K2021-12-31: $35.0K2022-12-31: $102.0K2023-12-31: $164.6K$164.6K
2019-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$164.6K+61.4%2024-04-16, From 2023-01-01
2022-12-31$102.0K+191.5%2024-04-16, From 2022-01-01
2021-12-31$35.0K+133.3%2023-04-18, From 2021-01-01
2020-12-31$15.0K-65.1%2022-04-15, From 2020-01-01
2019-12-31$43.0Kn/a2021-04-15, From 2019-01-01